期刊文献+

上海闸北区围绝经期妇女性功能障碍调查分析 被引量:6

原文传递
导出
摘要 目的调查分析上海闸北社区围绝经期妇女性功能障碍(FDS)发生情况,为延缓围绝经期妇女性功能障碍提供性知识的健康教育。方法选择2011年5月至9月上海闸北区北面区域社区居民中在本院进行健康体检的40~65岁围绝经期妇女825例为调查对象,并采用女性性功能指数(FSFI)问卷评估性功能调查,分析围绝经期妇女性功能障碍的发生率及相关影响因素。结果发放调查表825份,收回有效调查表746份,有效问卷回收率90.42%。本组40~65岁女性FSFI得分(16.45±4.33)分,FSD总的发生率为86.7%,围绝经期妇女随年龄的增长,FSn评分及单项评分逐渐下降(P〈0.05),FSD发生率升高(P〈0.05),以性满意度下降(72.9%)、性交疼痛(70.5%)和性高潮障碍(70.2%)为主。结论围绝经期妇女性功能障碍发生率高,伴有不同程度性功能障碍,以性满意度下降、性交疼痛和性高潮障碍为主。对围绝经期妇女进行性知识的健康教育,可改善其性生活质量,有利于延缓衰老。
出处 《中国医师杂志》 CAS 2012年第8期1141-1143,共3页 Journal of Chinese Physician
  • 相关文献

参考文献9

  • 1Hatzimouratidis K, Hatzichristou D. Sexual dysfunctions: Classifi- cations and definitions. J Sex Med, 2007,4( 1 ) :241-250.
  • 2金露青,段涛.老年妇女的性问题[J].中国实用妇科与产科杂志,2007,23(11):829-831. 被引量:1
  • 3Meston CM. Validation of the female sexual function idex(FSFI) in women with female orgasmic disorder and in women with hypo- active sexual desire disorder. J Sex Marital Ther, 2003,29 (1) : 39-46.
  • 4Song SH ,Jeon H, Kim SW, et al. The prevalence and risk factons of female sexual dysfunction in young Korean women : An intemet- based survey, J Sex Med,2008,5(7) : 1694-1701.
  • 5Aslan E,Beji NK, Gungor I, et al. Prevalence and risl factors for low sexual function in women: A study of 1,009 women in an out- patient clinic of a university hospital in Istanbul. J Sex Med, 2008,5(9) : 2044-2052.
  • 6曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2000,1.1224-1230.
  • 7Wiegel M,Meston C, Rosen R. The female sexual function index (FSFI):Cross-validation and development of clinical cutoff scores. J Sex Marital Ther, 2005, 31(1) :1-20.
  • 8Jiann BP, Su CC , Yu CC, et al. Risk factors for individual do- mains of female function . J Sex Med, 2009, 6 ( 12 ) : 3364-3375.
  • 9饶婷,张孝斌.女性性功能障碍的药物治疗进展[J].中华男科学杂志,2007,13(11):1023-1027. 被引量:7

二级参考文献35

  • 1沈逆,王彩琴,张元芳.对235名上海市静安社区内女性性功能的现况调查[J].中国男科学杂志,2006,20(5):56-57. 被引量:2
  • 2Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States : prevalence and predictors [ J ]. JAMA, 1999,281 : 537-544.
  • 3Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women[ J]. Curt Psychiatry Rep,2000,2 : 189-195.
  • 4Anastasiadis AG, Davis AR, Ghafar MA, et al. The epidemiology and definition of female sexual disorders [ J ]. World J Urol, 2002, 20: 74-78.
  • 5Nathorst-Boos J, Wiklund I, Mattson LA, et al. Is sexual life influenced by transdermal estrogen therapy? A double-blind placebo-controlled study in postmenopausal women [ J ]. Acta Obstet Gynecol Scand, 1993, 72: 656-660.
  • 6Mazer NA, Leiblum SR, Rosen RC. The brief index of sexual functioning for women (BISF-W) : a new scoring algorithm and comparison of normative and surgically menopausal populations [J]. Menopause,2000, 7: 350-363.
  • 7Rosen RC. Assessment of female sexual dysfunction: review of validated methods[ J]. Fertil Stefil, 2002, 77 ( Suppl 4) : S89- 93.
  • 8Utian WH, Shoupe D, Bachmafin G,et al. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate[ J]. Fertil Steril,2001,75 : 1065-1079.
  • 9Kaplan SA, Reis RB, Kohn I J, et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction[J]. Urology, 1999, 53:481-486.
  • 10Berman JR,Adhikari SP,Goldstein I.Anatomy and physiology of female sexual function and dysfunction:classification,evaluation and treatment options[J].Eur Urol,2000,38 (1):20-29.

共引文献314

同被引文献48

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部